title: Combined coagulation phase-directed factor Xa inhibition with heparin compounds and DX-9065a - a direct and selective antagonist.
authors.forename: Richard C
authors.initials: RC
authors.lastname: Becker
authors.forename: John
authors.initials: J
authors.lastname: Alexander
authors.forename: You Fu
authors.initials: YF
authors.lastname: Li
authors.forename: Edwin
authors.initials: E
authors.lastname: Bovill
authors.forename: Frederick A
authors.initials: FA
authors.lastname: Spencer
authors.forename: Thomas L
authors.initials: TL
authors.lastname: Robertson
authors.forename: Satoshi
authors.initials: S
authors.lastname: Kunitada
authors.forename: Christopher K
authors.initials: CK
authors.lastname: Dyke
authors.forename: Robert A
authors.initials: RA
authors.lastname: Harrington
mesh_terms: D000925:Anticoagulants / Q000008:administration & dosage / Q000494:pharmacology*; D001780:Blood Coagulation Tests; D002122:Calcium Chloride / Q000494:pharmacology; D002166:Camptothecin / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000494:pharmacology*; D004357:Drug Synergism; D017984:Enoxaparin / Q000494:pharmacology*; D015951:Factor Xa / Q000737:chemistry; D065427:Factor Xa Inhibitors; D006493:Heparin / Q000008:administration & dosage / Q000097:blood / Q000378:metabolism / Q000494:pharmacology*; D006495:Heparin, Low-Molecular-Weight / Q000097:blood; D006801:Humans; D012680:Sensitivity and Specificity
chemical_list: D000925:Anticoagulants; D017984:Enoxaparin; D065427:Factor Xa Inhibitors; D006495:Heparin, Low-Molecular-Weight; D006493:Heparin; D015951:Factor Xa; D002122:Calcium Chloride; C095887:exatecan; D002166:Camptothecin